MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pum…

Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...